Authors
Latest:
Focus on Evidence-Based Medicine: Improving Patient Outcomes and Managing Healthcare CostsThis brief commentary emphasizes the importance of applying evidence-based practices to ensure the safe and effective use of specialty medications to optimize treatment outcomes and minimize healthcare costs.
Latest:
Clinical Use of Generic Injectable Drugs in Hospitalized PatientsIn acute-patient-care settings, injectable drugs are used ubiquitously. Injectables offer several advantages over other administration routes, including precise and adjustable dosing, predictable bioavailability, and fast onset of action.
Latest:
New Student Guide to Preparing for a Career in Specialty PharmacyA how-to guide for pharmacy school students interested in pursuing a career in specialty pharmacy.
Latest:
Better Value, Better Care: How Value-based Management Models Can Improve Health and Lower Costs in Specialty PharmacyThe introduction of preferred formulary status for lower-cost generics was the first example of value-based pharmacy benefit management.
Latest:
Many Choices for Pharmacists Counseling Osteoarthritis PatientsDr. Pelegrin is a pharmacy manager with Publix and an associate clinical professor at the University of Florida College of Pharmacy (UF COP). At the time of this writing, Dr. Torres was a PharmD candidate at the UF COP.
Latest:
Psoriasis Treatment Cost Comparison: Biologics Versus Home PhototherapyAn estimation and comparison of the cost of home phototherapy versus biologics over a 3-year time horizon in patients with moderate-to-severe plaque psoriasis.
Latest:
Immunization Administration During Coronavirus Disease PandemicIn addition to adhering to the CDC recommendations, pharmacies should consider workflow changes intended to minimize risk to both patients and the pharmacy staff providing immunization services.
Latest:
Cognitive Impairment Becoming More Common in Patients with HIVPrevalence of cognitive impairment has increased among the HIV population while services for diagnosing and treating afflicted individuals remains scarce.
Latest:
Study Finds VA Education Program Improves Quality of Care for Older VeteransProgram establishes criteria to specify potentially inappropriate medications to avoid prescribing to older adults or should be used with caution when combined with other prescriptions.
Latest:
Association Between Sustained Glycated Hemoglobin Control and Healthcare CostsTotal cost of care for patients whose glycated hemoglobin levels were
Latest:
Comparative Effectiveness of Fidaxomicin for Treatment of Clostridium Difficile InfectionOur analysis models the clinical and economic value of fidaxomicin for the treatment of Clostridium difficile infection compared with metronidazole and vancomycin.
Latest:
Understanding Primary NonadherenceThe prevalence of primary nonadherence suggests that focusing solely on secondary nonadherence may miss an important piece of the puzzle.
Latest:
E-Cigarettes and Vaping: Another Cardiovascular Threat in Disguise?Since its introduction to the US market in 2003, questions have risen as to the safety, long-term consequences, and risk of cardiovascular detriments that e-cigarettes pose to users.
Latest:
Health Information Technology: Facilitating an Evolution in Health CareThe use of health information technology empowers pharmacists to provide enhanced care by harnessing a wealth of actionable information.
Latest:
The Impact of COVID-19 on Recent Pharmacy School GraduatesPharmacy students, particularly the graduating class of 2020, have been uniquely affected by the coronavirus disease 2019 (COVID-19) pandemic.
Latest:
The Beginning of a MovementIf independents have any chance of survival, we need to get into the game ourselves and teach the public what they don't know about PBMs.
Latest:
Factors Associated With Employee Participation in a Value-Based Insurance Design InitiativeWe describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.
Latest:
Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell CarcinomaStudy investigate the economic burden from the total costs, private insurance reimbursement, and out-of-pocket costs for oral TKI agents among metastatic RCC patients.
Latest:
The Changing Clinical Assessment: An Overview and Next-Level ChallengesThe clinical assessment has long been a cornerstone of patient-centric specialty pharmacy care.
Latest:
Costs Associated With Second-Line Therapies for Lung CancerErlotinib may confer an economic advantage for payers over docetaxel and pemetrexed for second-line treatment of lung cancer because of lower costs.
Latest:
Evaluating the Efficacy of Adjunctive Therapies Used to Treat COVID-19: The Role of Famotidine, Melatonin, and ThiamineH2-receptor antagonists, melatonin, and thiamine are some of the adjuvant treatments being evaluated for patients with COVID-19 due to their various immune-enhancing properties and possible antiviral effects.
Latest:
PQA Offers New CE Course on HIV Medication Use QualityPQA course provides an overview of how to build the best HIV treatment regimen and assess treatment outcomes.
Latest:
OTC, Prescription Drug Abuse Increasing Among AdolescentsNeighborhood pharmacists can provide support and information.
Latest:
Efficacy of Ezetimibe 2.5 mg With a Novel Tablet-Splitting StrategyThis prospective randomized study suggests that ezetimibe 2.5 mg, delivered as an ezetimibe/simvastatin tablet split into 4 parts, is clinically equivalent to a 10-mg dose.
